BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 9766668)

  • 1. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
    Hill SM; Blask DE
    Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
    Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
    J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture.
    Blask DE; Hill SM
    J Neural Transm Suppl; 1986; 21():433-49. PubMed ID: 3462341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
    Collier ME; Li C; Ettelaie C
    Mol Cancer Res; 2008 Dec; 6(12):1807-18. PubMed ID: 19074826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.
    Rose DP; Connolly JM; Liu XH
    Cancer Res; 1994 Dec; 54(24):6557-62. PubMed ID: 7987856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities.
    Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW
    Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
    Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
    Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.